NCT00960258 Phase I Study to Investigate Pharmacokinetics and Safety of BAY73-4506 in Asian (Japanese) Patients With Solid Tumors. Status COMPLETED Phase PHASE1
NCT00954278 Intra-patient Dose Escalation Study of Sorafenib in Advanced Non-small Cell Lung Cancer Status COMPLETED Phase PHASE1
NCT00944632 Dose Escalation of Different Concentrations of ZK 245186 in Atopic Dermatitis Status COMPLETED Phase PHASE2
NCT00943943 Granulocyte-colony Stimulating Factor (G-CSF) and Plerixafor Plus Sorafenib for Acute Myelogenous Leukemia (AML) With FLT3 Mutations Status COMPLETED Phase PHASE1
NCT00943072 Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Central Retinal Vein Occlusion (CRVO) Status COMPLETED Phase PHASE3
NCT00942682 Sorafenib in Combination With RAD001 in Patients With Advanced Neuroendocrine Tumors Status COMPLETED Phase PHASE1
NCT00941863 Study to Determine the Safety, Maximum Tolerated Dose, Pharmacokinetics of Sorafenib (BAY43-9006) Status COMPLETED Phase PHASE1
NCT00941057 Bioequivalence Study: 2 mg Estradiol Valerate (EV) and 3 mg Dienogest (DNG) Without and With Levomefolate Calcium Status COMPLETED Phase PHASE1
NCT00940342 Rituximab Plus Sargramostim (GM-CSF) In Patients With Chronic Lymphocytic Leukemia Status COMPLETED Phase PHASE2
NCT00936312 Females With Severe or Moderate Hemophilia A or B: an International Multi-center Study Status COMPLETED Phase N/A
NCT00934882 Study to Determine Safety, Pharmacokinetics, Pharmacodynamics of BAY73-4506 in Combination With mFOLFOX6 or FOLFIRI Status COMPLETED Phase PHASE1
NCT00932867 Surveillance of Efficacy and Safety of Drug PRITOR in patieNts With Arterial Hypertension, Who do Not Tolerate ACE inhibitoR Treatment Status COMPLETED Phase N/A
NCT00932555 EffeKt Taiwan- Efficacy and Safety of Long-term Treatment With KOGENATE® FS in Taiwan Status COMPLETED Phase N/A
NCT00931827 Acceptability of Long-term Progestin-only Contraception in Europe Status COMPLETED Phase N/A
NCT00930982 Evaluation of Cipro Inhale in Patients With Non-cystic Fibrosis Bronchiectasis Status COMPLETED Phase PHASE2
NCT00930605 The Effectiveness of Alemtuzumab Given in Combination With CHOP and ESHAP in Patients Newly Diagnosed With Peripheral T-Cell Lymphoma (PTCL) Status COMPLETED Phase PHASE2